Carregant...
Oxytocin and cardioprotection in diabetes and obesity
Oxytocin (OT) emerges as a drug for the treatment of diabetes and obesity. The entire OT system is synthesized in the rat and human heart. The direct myocardial infusion with OT into an ischemic or failing heart has the potential to elicit a variety of cardioprotective effects. OT treatment attenuat...
Guardat en:
| Publicat a: | BMC Endocr Disord |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4895973/ https://ncbi.nlm.nih.gov/pubmed/27268060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-016-0110-1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|